Form D · Other

AbX Biologics, Inc.

Canton, MA · CIK 0001783034

Offering snapshot reported Oct 11, 2019 · SEC filing

Reported sold
$1M
Offering amount: $1M
Investors reported
5
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 8, 2019
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$500K$1MJul 22, 2019: $350,000.00Jul 22, 2019Oct 11, 2019: $1,000,000.00Oct 11, 2019

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$350,000 → $1,000,000
  • Reported investors3 → 5

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 11, 2019Amendment$1,000,000$650,000vs Jul 22, 20195SEC filing
Jul 22, 2019Initial$350,000No comparison3SEC filing

Offering details

Securities
Debt, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-344776

Source: Form D, filed Oct 11, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Garren Hilow Director, Executive

Issuer details

Industry: Other (See others in industry)

Address:
480 Neponset Street, Suite 10 B
Canton, MA, 02021